The efficacy and toxicity of Methotrexate (MTX) monotherapy vs
... CI -8.84 to -4.30), WMD -3.46 (95% CI-4.84 to -2.08), WMD -9.72 (95% CI-14.70 to 4.75), WMD -11.57 (95% CI-19.31 to -3.83), WMD -12.10 (95% CI-19.84 to -4.36) and WMD -0.28 (95% CI -0.36 to -0.21) respectively]. However, significant difference was not found for ESR[5-7] [WMD -0.53 (95% CI-11.47 to 1 ...
... CI -8.84 to -4.30), WMD -3.46 (95% CI-4.84 to -2.08), WMD -9.72 (95% CI-14.70 to 4.75), WMD -11.57 (95% CI-19.31 to -3.83), WMD -12.10 (95% CI-19.84 to -4.36) and WMD -0.28 (95% CI -0.36 to -0.21) respectively]. However, significant difference was not found for ESR[5-7] [WMD -0.53 (95% CI-11.47 to 1 ...
midazolam sedation in paediatrics: comparative study of intranasal
... RESULTS: The Groups were comparable with respect to age, gender and weight (Table IV). Mean age for group I was 3.3 ± 3.1. Mean weight for group I is 13.4 ± 7.9 and for group S is 12.4 ± 5.8. Both the groups are comparable as far as age, sex, weight and ASA physical status. There was no significant ...
... RESULTS: The Groups were comparable with respect to age, gender and weight (Table IV). Mean age for group I was 3.3 ± 3.1. Mean weight for group I is 13.4 ± 7.9 and for group S is 12.4 ± 5.8. Both the groups are comparable as far as age, sex, weight and ASA physical status. There was no significant ...
ESC Guidelines for the management of acute without persistent ST-segment elevation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
ACR–SIR–SPR Practice Parameter for the Creation of a
... parameters, technical standards, or policies [128,129]. In addition, a minimum of 5 TIPS procedures must have been performed or supervised with documented success and complication rates that meet the threshold criteria listed in Appendix B and C. or 2. Completion of a radiology residency training pr ...
... parameters, technical standards, or policies [128,129]. In addition, a minimum of 5 TIPS procedures must have been performed or supervised with documented success and complication rates that meet the threshold criteria listed in Appendix B and C. or 2. Completion of a radiology residency training pr ...
Ketofol for bone marrow aspiration and lumbar puncture in Children
... given a 1:1 mixture of propofol and ketamine. Transient hypoxia occurred in 2.6% of patients, out of them one patient required bag valve mask ventilation (32). Short recovery time is an important and desirable end-point of a procedural sedation and analgesia regimen. There is compelling evidence sup ...
... given a 1:1 mixture of propofol and ketamine. Transient hypoxia occurred in 2.6% of patients, out of them one patient required bag valve mask ventilation (32). Short recovery time is an important and desirable end-point of a procedural sedation and analgesia regimen. There is compelling evidence sup ...
Diagnosis and Treatment of Common Headache Syndromes:A
... is almost always normal and abnormalities identified on physical examination in this patient population should raise concern. Appropriate use of diagnostic imaging including magnetic resonance imaging of the brain and cervical spine is indicated in those patients with a recent onset of headaches and ...
... is almost always normal and abnormalities identified on physical examination in this patient population should raise concern. Appropriate use of diagnostic imaging including magnetic resonance imaging of the brain and cervical spine is indicated in those patients with a recent onset of headaches and ...
MPG201667_abs
... malabsorption from three different families are presented. Two are Saudi Arab from the same family, the third is Syrian Arab and the fourth infant is Yemeni Arab. The mean age of the infant at the time of presentation was 6 months. They were first presented with chronic diarrhea and severe growth fa ...
... malabsorption from three different families are presented. Two are Saudi Arab from the same family, the third is Syrian Arab and the fourth infant is Yemeni Arab. The mean age of the infant at the time of presentation was 6 months. They were first presented with chronic diarrhea and severe growth fa ...
Lorazepam Injection, USP, CIV (4 mg/mL)
... require amputation (see WARNINGS). WARNINGS Use in Status Epilepticus Management of Status Epilepticus Status epilepticus is a potentially life-threatening condition associated with a high risk of permanent neurological impairment, if inadequately treated. The treatment of status, however, requires ...
... require amputation (see WARNINGS). WARNINGS Use in Status Epilepticus Management of Status Epilepticus Status epilepticus is a potentially life-threatening condition associated with a high risk of permanent neurological impairment, if inadequately treated. The treatment of status, however, requires ...
abnormalities, coronary artery disease, or other serious heart problems. (5.1)
... Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardi ...
... Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardi ...
Full Prescribing Information for CONCERTA® (methylphenidate HCl)
... Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardi ...
... Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD. Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardi ...
Global Strategy for the Diagnosis, Management, and Prevention of
... care and health care policy, and to encourage an expanded level of research interest in this highly prevalent disease. One strategy to help achieve the objectives of GOLD is to provide health care workers, health care authorities, and the general public with state-of-the-art information about COPD a ...
... care and health care policy, and to encourage an expanded level of research interest in this highly prevalent disease. One strategy to help achieve the objectives of GOLD is to provide health care workers, health care authorities, and the general public with state-of-the-art information about COPD a ...
1
... Adults — For most patients, initiate CYMBALTA 60 mg once daily. For some patients, it may be desirable to start at 30 mg once daily for 1 week, to allow patients to adjust to the medication before increasing to 60 mg once daily. While a 120 mg once daily dose was shown to be effective, there is no e ...
... Adults — For most patients, initiate CYMBALTA 60 mg once daily. For some patients, it may be desirable to start at 30 mg once daily for 1 week, to allow patients to adjust to the medication before increasing to 60 mg once daily. While a 120 mg once daily dose was shown to be effective, there is no e ...
DOCEtaxel - Cancer Care Ontario
... may be severe with ascites, pleural or pericardial effusions. Peripheral edema can be treated with standard measures (e.g. sodium restriction, diuretics). Premedication with oral corticosteroids has been reported to delay the onset and decrease the severity of fluid retention, and all patients sho ...
... may be severe with ascites, pleural or pericardial effusions. Peripheral edema can be treated with standard measures (e.g. sodium restriction, diuretics). Premedication with oral corticosteroids has been reported to delay the onset and decrease the severity of fluid retention, and all patients sho ...
National Journal of Research in Ayurved Science
... daily practice. A clinical trial was conducted ...
... daily practice. A clinical trial was conducted ...
Hypertension in India (1/2) - The Association of Physicians of India
... • Various cardiovascular changes in hypertension • Hypertension and CAD • Hypertension and HF (REF, PEF) • Hypertension and atherosclerosis – vascular aging • Cardiovascular emergencies in hypertension. ...
... • Various cardiovascular changes in hypertension • Hypertension and CAD • Hypertension and HF (REF, PEF) • Hypertension and atherosclerosis – vascular aging • Cardiovascular emergencies in hypertension. ...
Managing patients on dabigatran
... This guideline has been prepared to promote and facilitate standardisation and consistency of practice, using a multidisciplinary approach. Information in this guideline is current at time of publication. The Department of Health, Queensland Government does not accept liability to any person for los ...
... This guideline has been prepared to promote and facilitate standardisation and consistency of practice, using a multidisciplinary approach. Information in this guideline is current at time of publication. The Department of Health, Queensland Government does not accept liability to any person for los ...
Valsartan ratiopharm 40 mg 80 mg 120 mg 160 mg film
... with an ACE-inhibitor. In patients with heart failure, the triple combination of an ACEinhibitor, a beta blocker and valsartan has not shown any clinical benefit (see section 5.1). This combination apparently increases the risk for adverse events and is therefore not recommended. Triple combination ...
... with an ACE-inhibitor. In patients with heart failure, the triple combination of an ACEinhibitor, a beta blocker and valsartan has not shown any clinical benefit (see section 5.1). This combination apparently increases the risk for adverse events and is therefore not recommended. Triple combination ...
SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2.
... Tendinitis may rarely occur. It most frequently involves the Achilles tendon and may lead to tendon rupture. Tendinitis and tendon rupture, sometimes bilateral, may occur within 48 hours of starting treatment with levofloxacin and have been reported up to several months after discontinuation of trea ...
... Tendinitis may rarely occur. It most frequently involves the Achilles tendon and may lead to tendon rupture. Tendinitis and tendon rupture, sometimes bilateral, may occur within 48 hours of starting treatment with levofloxacin and have been reported up to several months after discontinuation of trea ...
Safe and Secure Handling of Medicines in Hospital Wards, Theatres
... This policy document covers all aspects of medicine procurement, storage, distribution and administration within the hospital environment. It is not intended to address the specific clinical issues that relate to therapeutic choice, medication efficacy and preventing adverse effects from medication. ...
... This policy document covers all aspects of medicine procurement, storage, distribution and administration within the hospital environment. It is not intended to address the specific clinical issues that relate to therapeutic choice, medication efficacy and preventing adverse effects from medication. ...
Lexapro Name of Medicine
... The long-term efficacy of escitalopram in the treatment of SAD is based on the results from a placebo-controlled, fixed-dose active-reference study (paroxetine) and a relapse prevention study. In the placebo-controlled, active-reference study, escitalopram was effective both in the short- and in the ...
... The long-term efficacy of escitalopram in the treatment of SAD is based on the results from a placebo-controlled, fixed-dose active-reference study (paroxetine) and a relapse prevention study. In the placebo-controlled, active-reference study, escitalopram was effective both in the short- and in the ...
product information - cardizem® cd
... multiforme and/or exfoliative dermatitis have also been infrequently reported. Should a dermatological reaction persist, the drug should be discontinued. Use in Diabetics Diltiazem should be used with caution in patients suffering from diabetes. Like other calcium channel blockers, diltiazem influen ...
... multiforme and/or exfoliative dermatitis have also been infrequently reported. Should a dermatological reaction persist, the drug should be discontinued. Use in Diabetics Diltiazem should be used with caution in patients suffering from diabetes. Like other calcium channel blockers, diltiazem influen ...
Butz AM, Syron L, Johnson B, Spaulding J, Walker M, Bollinger ME. Home-based asthma self-management education for inner city children. Public Health Nurs. 2005;22(3): p.189-99.
... Early and accurate identification of asthma symptoms (symptom experience), if allied with appropriate treatment and accurate use of asthma medications including administering medications via a nebulizer device (symptom management), is hypothesized to improve outcomes defined as a decrease in frequen ...
... Early and accurate identification of asthma symptoms (symptom experience), if allied with appropriate treatment and accurate use of asthma medications including administering medications via a nebulizer device (symptom management), is hypothesized to improve outcomes defined as a decrease in frequen ...
diclofenac - Endo Pharmaceuticals
... diclofenac treatment. In a large, open-label, controlled trial of 3,700 patients treated for 2-6 months, patients were monitored first at 8 weeks and 1,200 patients were monitored again at 24 weeks. Meaningful elevations of ALT and/or AST occurred in about 4% of patients and included marked elevatio ...
... diclofenac treatment. In a large, open-label, controlled trial of 3,700 patients treated for 2-6 months, patients were monitored first at 8 weeks and 1,200 patients were monitored again at 24 weeks. Meaningful elevations of ALT and/or AST occurred in about 4% of patients and included marked elevatio ...
Arrow - Citalopram
... SSRIs (and venlafaxine) compared to those treated with placebo. Consequently, citalopram should not be used in children and adolescents less than 18 years of age. Clinical worsening and suicide risk Patients of any age with major depressive disorder may experience worsening of their depression and/o ...
... SSRIs (and venlafaxine) compared to those treated with placebo. Consequently, citalopram should not be used in children and adolescents less than 18 years of age. Clinical worsening and suicide risk Patients of any age with major depressive disorder may experience worsening of their depression and/o ...